Total Payments
$619.55
2024 Payments
$281.53
Companies
19
Transactions
29
Medicare Patients
6,331
Medicare Billing
$456,867
Payment Breakdown by Category
Food & Beverage$619.55 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $619.55 | 29 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $165.71 | 1 | $0 (2024) |
| Novo Nordisk Inc | $87.36 | 6 | $0 (2019) |
| Gilead Sciences, Inc. | $46.02 | 2 | $0 (2024) |
| ABBVIE INC. | $41.84 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $30.70 | 2 | $0 (2019) |
| Alkermes, Inc. | $27.96 | 1 | $0 (2024) |
| Amgen Inc. | $25.15 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $23.96 | 2 | $0 (2019) |
| Insmed, Inc. | $22.93 | 1 | $0 (2021) |
| Ironwood Pharmaceuticals, Inc | $22.09 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $281.53 | 6 | AIMMUNE THERAPEUTICS, INC. ($165.71) |
| 2023 | $20.09 | 1 | NESTLE HEALTHCARE NUTRITION INC. ($20.09) |
| 2021 | $22.93 | 1 | Insmed, Inc. ($22.93) |
| 2019 | $125.60 | 9 | Novo Nordisk Inc ($54.91) |
| 2018 | $40.04 | 3 | Novo Nordisk Inc ($17.33) |
| 2017 | $129.36 | 9 | Amgen Inc. ($25.15) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: CNS | ||||||
| 07/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.71 | General |
| 05/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.31 | General |
| 02/20/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $165.71 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 02/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/25/2021 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Respiratory | ||||||
| 11/26/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: STRUCTURAL HEART | ||||||
| 11/14/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Diabetes | ||||||
| 11/14/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Diabetes | ||||||
| 10/15/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE, XIFAXAN | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/02/2019 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Bystolic | Food and Beverage | Cash or cash equivalent | $13.04 | General |
| Category: Cardiovascular | ||||||
| 07/23/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/05/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/05/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.91 | General |
| Category: Diabetes | ||||||
| 01/22/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Diabetes | ||||||
| 11/06/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Diabetes | ||||||
| 12/14/2017 | Ironwood Pharmaceuticals, Inc | DUZALLO (Drug), LINZESS, VIBERZI | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Rheumatology | ||||||
| 10/12/2017 | Depomed, Inc. | Nucynta (Drug), Zipsor | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Pain | ||||||
| 09/12/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: DIABETES | ||||||
| 06/13/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Endocrinology | ||||||
| 05/23/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 115 | 156 | $32,848 | $12,555 |
| 2022 | 31 | 1,976 | 3,040 | $420,352 | $111,482 |
| 2021 | 30 | 2,125 | 3,444 | $439,194 | $196,213 |
| 2020 | 31 | 2,115 | 3,443 | $398,260 | $136,617 |
Total Patients
6,331
Total Services
10,083
Medicare Billing
$456,867
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 59 | $14,100 | $5,370 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 38 | $12,200 | $4,873 | 39.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 15 | 15 | $5,250 | $1,791 | 34.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 18 | 19 | $1,096 | $322.62 | 29.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 25 | $202.50 | $198.50 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 438 | 903 | $198,912 | $39,417 | 19.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 358 | 358 | $75,538 | $17,483 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 212 | 278 | $42,531 | $9,182 | 21.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 33 | 33 | $9,570 | $9,176 | 95.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 105 | 105 | $7,875 | $7,183 | 91.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 28 | 29 | $13,493 | $3,022 | 22.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 105 | 105 | $4,389 | $2,865 | 65.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 35 | 39 | $11,415 | $2,848 | 24.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 21 | 21 | $3,150 | $2,782 | 88.3% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 11 | 11 | $2,915 | $2,751 | 94.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 43 | 244 | $11,224 | $2,185 | 19.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 42 | 54 | $4,290 | $1,961 | 45.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 104 | 119 | $6,664 | $1,715 | 25.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 63 | 63 | $1,802 | $1,667 | 92.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,965 | $1,253 | 31.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 12 | 12 | $4,089 | $934.57 | 22.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 15 | 31 | $932.00 | $508.10 | 54.5% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 23 | 29 | $1,702 | $504.90 | 29.7% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 30 | 30 | $1,582 | $501.98 | 31.7% |
| 85610 | Blood test, clotting time | Office | 2022 | 15 | 109 | $981.00 | $462.17 | 47.1% |
About Dr. Adam Brank, M.D
Dr. Adam Brank, M.D is a Addiction Medicine healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033208087.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Brank, M.D has received a total of $619.55 in payments from pharmaceutical and medical device companies, with $281.53 received in 2024. These payments were reported across 29 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($619.55).
As a Medicare-enrolled provider, Brank has provided services to 6,331 Medicare beneficiaries, totaling 10,083 services with total Medicare billing of $456,867. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction Medicine
- Other Specialties Internal Medicine
- Location Lincoln, NE
- Active Since 10/11/2006
- Last Updated 08/16/2023
- Taxonomy Code 207RA0401X
- Entity Type Individual
- NPI Number 1033208087
Products in Payments
- ZENPEP (Drug) $185.80
- VRAYLAR (Drug) $41.84
- Victoza (Drug) $32.45
- XIFAXAN (Drug) $30.70
- VIVITROL (Drug) $27.96
- Tresiba (Drug) $27.94
- Ozempic (Drug) $26.97
- Prolia (Biological) $25.15
- ENTRESTO (Drug) $23.96
- Arikayce (Drug) $22.93
- Nucynta (Drug) $18.78
- TOUJEO (Drug) $14.80
- WATCHMAN (Device) $13.57
- Livalo (Drug) $13.04
- XARELTO (Drug) $12.14
- STIOLTO RESPIMAT (Drug) $11.39
- ZURAMPIC (Drug) $11.33
- BELSOMRA (Drug) $11.23
- SYMBICORT (Drug) $10.79
- DUZALLO (Drug) $10.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.